Correlation Between Neximmune and Timber Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neximmune and Timber Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Timber Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Timber Pharmaceuticals, you can compare the effects of market volatilities on Neximmune and Timber Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Timber Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Timber Pharmaceuticals.
Diversification Opportunities for Neximmune and Timber Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neximmune and Timber is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Timber Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Timber Pharmaceuticals and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Timber Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Timber Pharmaceuticals has no effect on the direction of Neximmune i.e., Neximmune and Timber Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neximmune and Timber Pharmaceuticals
If you would invest 172.00 in Timber Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Timber Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Neximmune vs. Timber Pharmaceuticals
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Timber Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neximmune and Timber Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and Timber Pharmaceuticals
The main advantage of trading using opposite Neximmune and Timber Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Timber Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Timber Pharmaceuticals will offset losses from the drop in Timber Pharmaceuticals' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Timber Pharmaceuticals vs. Salarius Pharmaceuticals | Timber Pharmaceuticals vs. Nutriband | Timber Pharmaceuticals vs. Aileron Therapeutics | Timber Pharmaceuticals vs. Artelo Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |